Rothschild & Co Asset Management US’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-80,270
Closed -$1.51M 561
2017
Q2
$1.51M Sell
80,270
-3,631
-4% -$50.6K 0.02% 343
2017
Q1
$1.03M Sell
83,901
-6,448
-7% -$93.9K 0.01% 366
2016
Q4
$1.44M Buy
90,349
+74,287
+463% +$1.24M 0.02% 365
2016
Q3
$292K Buy
16,062
+396
+3% +$6.47K 0.01% 514
2016
Q2
$249K Buy
+15,666
New +$234K ﹤0.01% 547

Other funds holding OTIC

Rothschild & Co Asset Management US's OTIC Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of Otonomy, Inc. (OTIC) in Q3 2017, closing a stake of 80,270 shares — an estimated $1.51M sold.

Rothschild & Co Asset Management US first reported a position in OTIC in Q2 2016 and held it in 5 quarters. The position peaked at $1.51M in Q2 2017. 84 funds tracked by Wall St. Rank hold OTIC as of Q3 2017.

  • Rothschild & Co Asset Management US reported no remaining Otonomy, Inc. position as of Q3 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 80,270 Otonomy, Inc. shares in Q3 2017, an estimated $1.51M.
  • Rothschild & Co Asset Management US first reported a position in Otonomy, Inc. in Q2 2016 and held it in 5 quarters.
  • Rothschild & Co Asset Management US's Otonomy, Inc. position peaked at $1.51M in Q2 2017.
  • 84 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.